Related Experiment Video
Updated: Jun 20, 2026

07:30
HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice
Published on: July 9, 2016
Methamphetamine- and 3,4-methylenedioxymethamphetamine-induced behavioral changes in histamine H3-receptor knockout
Tomohiro Okuda1, Dongying Zhang, He Shao
1Department of Pharmacology, Tohoku University School of Medicine, Sendai, Japan.
Journal of Pharmacological Sciences
|September 29, 2009
Summary
Mice lacking histamine H(3) receptors showed reduced locomotion in response to psychostimulants like methamphetamine. However, these histamine H(3) receptor-gene knockout mice still developed behavioral sensitization and reward, indicating complex effects.
Area of Science:
- Neuroscience
- Pharmacology
- Genetics
Background:
- Histamine H(3) receptors modulate neurotransmitter release, including dopamine.
- Histaminergic neurons are known to influence behavioral responses to psychostimulants.
Purpose of the Study:
- To investigate the role of histamine H(3) receptors in psychostimulant-induced behavioral sensitization and reward.
- To compare the effects of methamphetamine and MDMA in histamine H(3) receptor-gene knockout (H3KO) mice and wild-type (WT) counterparts.
Main Methods:
- Assessment of locomotor activity, conditioned place preference (CPP), and c-Fos expression.
- Utilized H3KO mice and WT mice treated with methamphetamine (METH) and 3,4-methylenedioxymethamphetamine (MDMA).
Main Results:
- H3KO mice exhibited lower METH/MDMA-induced locomotion compared to WT mice.
- Locomotor sensitization to METH/MDMA occurred in both H3KO and WT mice.
- No significant differences in CPP were observed between H3KO and WT mice.
- METH treatment reduced c-Fos expression in the caudate-putamen of H3KO mice compared to WT mice, but not in the nucleus accumbens.
Conclusions:
- Histamine H(3) receptor deficiency may inhibit psychostimulant-induced increases in locomotion.
- The reward pathways associated with psychostimulants appear less affected by histamine H(3) receptor deficiency.

